FGRCX
Price
$32.87
Change
-$0.28 (-0.84%)
Updated
Jul 13 closing price
Net Assets
6.98B
VSMPX
Price
$337.67
Change
-$2.70 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

FGRCX vs VSMPX

FGRCX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
FGRCX vs. VSMPX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGRCX is a Buy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.3T vs. FGRCX (6.98B). VSMPX pays higher dividends than FGRCX: VSMPX (1.06) vs FGRCX (0.03). FGRCX was incepted earlier than VSMPX: FGRCX (18 years) vs VSMPX (11 years). FGRCX (1.64) is less costly to investors than VSMPX (0.02). FGRCX is a more actively managed with annual turnover of: 15.00 vs. VSMPX (3.00). FGRCX has a lower initial minimum investment than VSMPX: FGRCX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 21.48 vs. FGRCX (19.28). FGRCX return over 5 years is better than : 80.80 vs. VSMPX (66.52).
FGRCXVSMPXFGRCX / VSMPX
Total Expense Ratio1.640.028,200%
Annual Report Gross Expense Ratio1.640.028,200%
Fund Existence18 years11 years-
Gain YTD11.09211.20699%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.98B2.3T0%
Annual Yield % from dividends0.031.063%
Returns for 1 year19.2821.4890%
Returns for 3 years75.9967.03113%
Returns for 5 years80.8066.52121%
Returns for 10 years113.96239.4348%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSNX21.35N/A
N/A
Vanguard Real Estate Index Institutional
PCAOX91.03N/A
N/A
Principal Capital Appreciation R3
GARIX23.88N/A
N/A
Gotham Absolute Return Institutional
RLAIX24.27N/A
N/A
T. Rowe Price Latin America I
MCYCX15.72-0.49
-3.02%
NYLI Candriam Emerging Markets Eq Cl C